During the last 30 years, the incidence of oesophagealadenocarcinoma has increased rapidly.
2
Methods: Consecutive patients with oesophagealadenocarcinoma who underwent PET-CT before neoadjuvant chemotherapy and resection were included.
3
Patients with Barrett's oesophagus have an increased risk of developing oesophagealadenocarcinoma and should be kept under surveillance.
4
There are few epidemiological data on the dietary risk factors of Barrett's oesophagus, a precursor of oesophagealadenocarcinoma.
5
The incidence of oesophagealadenocarcinoma (EADC) is rapidly increasing in Western countries and obesity is thought to be a major risk factor.
1
Barrett's esophagus is an important step in the pathway to esophagealadenocarcinoma.
2
Context: The incidence of esophagealadenocarcinoma is rising and has surpassed squamous cell carcinoma.
3
Future studies of trastuzumab in esophagealadenocarcinoma are indicated.
4
Barrett's esophagus (BE) is the principal risk factor for esophagealadenocarcinoma.
5
Barrett's esophagus is the precursor lesion for esophagealadenocarcinoma.
Uso de adenocarcinoma of the esophagus em inglês
1
Incidence rates for adenocarcinomaoftheesophagus and gastric cardia have been rising rapidly.
2
Methods and materials: Patients with adenocarcinomaoftheesophagus without distant organ metastases were eligible.
3
Incidence increased for several cancers, including pancreas, kidney, and adenocarcinomaoftheesophagus, which are associated with excess weight.
4
Patients and methods: Sixty-one patients with advanced, surgically unresectable, or metastatic squamous cell or adenocarcinomaoftheesophagus were treated.
5
A retrospective analysis should compare the two operative approaches, transhiatal or transthoracic resection in patients suffering from adenocarcinomaoftheesophagus.
6
Introduction: Even after potentially curative esophagectomy, the majority of patients with adenocarcinomaoftheesophagus or gastroesophageal junction die due to cancer recurrence.
7
Conclusions: There were significant differences in the gene profile between patients with adenocarcinomaoftheesophagus responding to neoadjuvant chemotherapy compared with nonresponding patients.
8
In summary, tumor uPA content as determined by ELISA appears to be a powerful, independent prognostic factor for survival in adenocarcinomaoftheesophagus.
9
Results: Compared to nonneoplastic epithelium, there was a significant increase in YAP cytoplasmic and nuclear localization in high-grade dysplastic epithelium and adenocarcinomaoftheesophagus.
10
Results: The median follow-up time for 518 patients was 29.3 months (range 1-149.2); all patients had adenocarcinomaoftheesophagus.
11
Adenocarcinomaoftheesophagus and gastroesophageal junction (GEJ) has shown a remarkable increase during recent decades.
12
Adenocarcinomaoftheesophagus continues to increase in incidence and has become a significant health problem in Western countries.